☰

Miriam Z. Mintzer, Ph.D. - Publications

Affiliations: 
2014 Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States 
 2014- National Insitutes of Health, Bethesda, MD, United States 
Area:
Behavioral pharmacology, cognition
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

61 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Sweeney MM, Rass O, DiClemente C, Schacht RL, Vo HT, Fishman MJ, Leoutsakos JS, Mintzer MZ, Johnson MW. Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial. Journal of Child & Adolescent Substance Abuse. 27: 211-226. PMID 30524179 DOI: 10.1080/1067828X.2018.1451793  0.793
2016 Sweeney MM, Rass O, Johnson PS, Strain EC, Berry MS, Vo HT, Fishman MJ, Munro CA, Rebok GW, Mintzer MZ, Johnson MW. Initial feasibility and validity of a prospective memory training program in a substance use treatment population. Experimental and Clinical Psychopharmacology. 24: 390-399. PMID 27690506 DOI: 10.1037/Pha0000091  0.806
2015 Rass O, Schacht RL, Buckheit K, Johnson MW, Strain EC, Mintzer MZ. A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug and Alcohol Dependence. 156: 38-46. PMID 26404954 DOI: 10.1016/J.Drugalcdep.2015.08.012  0.814
2015 Kleykamp BA, Vandrey RG, Bigelow GE, Strain EC, Mintzer MZ. Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers. The American Journal of Drug and Alcohol Abuse. 41: 251-6. PMID 25584897 DOI: 10.3109/00952990.2014.987348  0.769
2015 Rass O, Umbricht A, Bigelow GE, Strain EC, Johnson MW, Mintzer MZ. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 29: 237-46. PMID 25365653 DOI: 10.1037/Adb0000027  0.804
2014 Vo HT, Schacht R, Mintzer M, Fishman M. Working memory impairment in cannabis- and opioid-dependent adolescents. Substance Abuse. 35: 387-90. PMID 25148203 DOI: 10.1080/08897077.2014.954027  0.684
2014 Umbricht A, DeFulio A, Winstanley EL, Tompkins DA, Peirce J, Mintzer MZ, Strain EC, Bigelow GE. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. Drug and Alcohol Dependence. 140: 92-100. PMID 24814607 DOI: 10.1016/J.Drugalcdep.2014.03.033  0.337
2014 Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Experimental and Clinical Psychopharmacology. 22: 248-56. PMID 24548244 DOI: 10.1037/A0035712  0.816
2014 Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC. A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine. The Journal of Pharmacology and Experimental Therapeutics. 348: 217-26. PMID 24227768 DOI: 10.1124/Jpet.113.209478  0.348
2014 Umbricht A, Rass O, Bigelow G, Strain EC, Tompkins DA, Mintzer M. Correlates of drug use severity and HIV risk behaviors in cocaine- and opiate-dependent patients Drug and Alcohol Dependence. 140: e230. DOI: 10.1016/J.Drugalcdep.2014.02.637  0.69
2014 Umbricht A, Mintzer M, Rass O, Bigelow G, Johnson MW, Strain E, Tompkins DA. Correlates of impaired cognitive performance in cocaine- and opioid-dependent patients Drug and Alcohol Dependence. 140: e230. DOI: 10.1016/J.Drugalcdep.2014.02.636  0.791
2014 Schacht RL, Johnson MW, Strain EC, Mintzer M. Effects of working-memory training in methadone maintenance patients Drug and Alcohol Dependence. 140: e197. DOI: 10.1016/J.Drugalcdep.2014.02.550  0.643
2014 Rass O, Umbricht A, Bigelow G, Strain EC, Mintzer M. Topiramate impairs cognitive function in cocaine-dependent individuals maintained on methadone Drug and Alcohol Dependence. 140: e183. DOI: 10.1016/J.Drugalcdep.2014.02.512  0.745
2013 Carter LP, Kleykamp BA, Griffiths RR, Mintzer MZ. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers. Psychopharmacology. 226: 53-63. PMID 23096769 DOI: 10.1007/S00213-012-2883-X  0.831
2013 Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug and Alcohol Dependence. 128: 206-13. PMID 22989498 DOI: 10.1016/J.Drugalcdep.2012.08.025  0.825
2013 Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence. 128: 64-70. PMID 22921474 DOI: 10.1016/J.Drugalcdep.2012.08.001  0.742
2013 Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Corrigendum to Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans [Drug Alcohol Depend. 128 (2013) 206-213] Drug and Alcohol Dependence. 133: 294. DOI: 10.1016/J.Drugalcdep.2013.06.006  0.769
2013 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens Psychopharmacology. 228: 513-513. DOI: 10.1007/S00213-013-3172-Z  0.785
2012 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 223: 1-15. PMID 22526529 DOI: 10.1007/S00213-012-2680-6  0.804
2012 Henry PK, Umbricht A, Kleykamp BA, Vandrey R, Strain EC, Bigelow GE, Mintzer MZ. Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence. Drug and Alcohol Dependence. 124: 167-71. PMID 22266090 DOI: 10.1016/J.Drugalcdep.2011.12.009  0.781
2012 Kleykamp BA, Griffiths RR, McCann UD, Smith MT, Mintzer MZ. Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use. Experimental and Clinical Psychopharmacology. 20: 28-39. PMID 21928913 DOI: 10.1037/A0025237  0.795
2012 Marvel CL, Faulkner ML, Strain EC, Mintzer MZ, Desmond JE. An fMRI investigation of cerebellar function during verbal working memory in methadone maintenance patients. Cerebellum (London, England). 11: 300-10. PMID 21892700 DOI: 10.1007/S12311-011-0311-0  0.436
2010 Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology. 211: 457-66. PMID 20589494 DOI: 10.1007/S00213-010-1919-3  0.766
2010 Mintzer MZ, Lanier RK, Lofwall MR, Bigelow GE, Strain EC. Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug and Alcohol Dependence. 111: 265-8. PMID 20538418 DOI: 10.1016/J.Drugalcdep.2010.05.002  0.784
2010 Mintzer MZ, Kleykamp BA, Griffiths RR. Dose effects of triazolam and scopolamine on metamemory. Experimental and Clinical Psychopharmacology. 18: 17-31. PMID 20158291 DOI: 10.1037/A0018061  0.832
2010 Kleykamp BA, Griffiths RR, Mintzer MZ. Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Experimental and Clinical Psychopharmacology. 18: 1-16. PMID 20158290 DOI: 10.1037/A0018407  0.808
2009 Carter LP, Griffiths RR, Mintzer MZ. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacology. 206: 141-54. PMID 19543883 DOI: 10.1007/S00213-009-1589-1  0.835
2009 Carter LP, Mintzer MZ, Griffiths RR. Amnestic effects of sodium oxybate are less than those of triazolam-reply to Drs. Zvosec and Smith Psychopharmacology. 207: 511-512. DOI: 10.1007/S00213-009-1664-7  0.766
2007 Mintzer MZ, Griffiths RR. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. Cognitive, Affective & Behavioral Neuroscience. 7: 120-9. PMID 17672383 DOI: 10.3758/Cabn.7.2.120  0.685
2007 Mintzer MZ, Griffiths RR. A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal. Psychopharmacology. 192: 425-40. PMID 17342474 DOI: 10.1007/S00213-007-0726-Y  0.714
2006 Lofwall MR, Griffiths RR, Mintzer MZ. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults. Experimental and Clinical Psychopharmacology. 14: 439-49. PMID 17115871 DOI: 10.1037/1064-1297.14.4.439  0.712
2006 Curran HV, Mintzer MZ. Psychopharmacology of memory. Psychopharmacology. 188: 393-6. PMID 17058106 DOI: 10.1007/S00213-006-0580-3  0.399
2006 Carter LP, Richards BD, Mintzer MZ, Griffiths RR. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2537-51. PMID 16880774 DOI: 10.1038/Sj.Npp.1301146  0.831
2006 Mintzer MZ, Kuwabara H, Alexander M, Brasic JR, Ye W, Ernst M, Griffiths RR, Wong DF. Dose effects of triazolam on brain activity during episodic memory encoding: a PET study. Psychopharmacology. 188: 445-61. PMID 16847681 DOI: 10.1007/S00213-006-0446-8  0.669
2005 Mintzer MZ, Griffiths RR. Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine. Experimental and Clinical Psychopharmacology. 13: 336-47. PMID 16366764 DOI: 10.1037/1064-1297.13.4.336  0.715
2005 Mintzer MZ, Griffiths RR. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers. Behavioural Pharmacology. 16: 579-84. PMID 16170235 DOI: 10.1097/01.Fbp.0000172736.11994.3C  0.669
2005 Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug and Alcohol Dependence. 78: 225-30. PMID 15845327 DOI: 10.1016/J.Drugalcdep.2004.10.008  0.595
2005 Mintzer MZ, Griffiths RR. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure. Psychopharmacology. 178: 259-67. PMID 15452683 DOI: 10.1007/S00213-004-2009-1  0.615
2004 Mintzer MZ, Correia CJ, Strain EC. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug and Alcohol Dependence. 74: 205-9. PMID 15099664 DOI: 10.1016/J.Drugalcdep.2003.12.008  0.579
2003 Mintzer MZ, Griffiths RR, Hirshman E. A paradoxical dissociation in the effects of midazolam on recollection and automatic processes in the process dissociation procedure. The American Journal of Psychology. 116: 213-37. PMID 12762176 DOI: 10.2307/1423578  0.626
2003 Mintzer MZ, Griffiths RR. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal. Journal of Psychopharmacology (Oxford, England). 17: 17-29. PMID 12680736 DOI: 10.1177/0269881103017001689  0.705
2003 Mintzer MZ, Griffiths RR. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes. Experimental and Clinical Psychopharmacology. 11: 56-72. PMID 12622344 DOI: 10.1037//1064-1297.11.1.56  0.726
2003 Mintzer MZ. Triazolam-induced amnesia and the word-frequency effect in recognition memory: Support for a dual process account Journal of Memory and Language. 48: 596-602. DOI: 10.1016/S0749-596X(03)00004-4  0.386
2002 Mintzer MZ, Griffiths RR. Alcohol and triazolam: differential effects on memory, psychomotor performance and subjective ratings of effects. Behavioural Pharmacology. 13: 653-8. PMID 12478216 DOI: 10.1097/00008877-200212000-00007  0.672
2002 Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence. 67: 41-51. PMID 12062778 DOI: 10.1016/S0376-8716(02)00013-3  0.632
2001 Mintzer MZ, Griffiths RR. Alcohol and false recognition: a dose-effect study. Psychopharmacology. 159: 51-7. PMID 11797069 DOI: 10.1007/S002130100893  0.637
2001 Mintzer MZ, Griffiths RR, Contoreggi C, Kimes AS, London ED, Ernst M. Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 744-56. PMID 11682258 DOI: 10.1016/S0893-133X(01)00280-9  0.647
2001 Mintzer MZ, Allen RP, Griffiths RR. Investigation of preference for nightly triazolam versus placebo in moderate social alcohol drinkers. Journal of Psychopharmacology (Oxford, England). 15: 3-8. PMID 11277606 DOI: 10.1177/026988110101500101  0.62
2001 Mintzer MZ, Griffiths RR. Acute dose-effects of scopolamine on false recognition. Psychopharmacology. 153: 425-33. PMID 11243489 DOI: 10.1007/S002130000592  0.689
2001 Mintzer MZ, Griffiths RR. False Recognition in Triazolam-Induced Amnesia Journal of Memory and Language. 44: 475-492. DOI: 10.1006/Jmla.2000.2746  0.658
2000 Mintzer MZ, Griffiths RR. Acute effects of triazolam on false recognition. Memory & Cognition. 28: 1357-65. PMID 11219963 DOI: 10.3758/Bf03211836  0.703
1999 Mintzer MZ, Snodgrass JG. The picture superiority effect: support for the distinctiveness model. The American Journal of Psychology. 112: 113-46. PMID 10696280  0.606
1999 Mintzer MZ, Stoller KB, Griffiths RR. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 147: 200-9. PMID 10591888 DOI: 10.1007/S002130051161  0.637
1999 Mintzer MZ, Griffiths RR. Triazolam and zolpidem: effects on human memory and attentional processes. Psychopharmacology. 144: 8-19. PMID 10379619 DOI: 10.1007/S002130050971  0.707
1999 Mintzer MZ, Griffiths RR. Selective effects of zolpidem on human memory functions. Journal of Psychopharmacology (Oxford, England). 13: 18-31. PMID 10221356 DOI: 10.1177/026988119901300103  0.685
1998 Mintzer MZ, Griffiths RR. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability. Drug and Alcohol Dependence. 53: 49-66. PMID 10933340 DOI: 10.1016/S0376-8716(98)00110-0  0.71
1998 Mintzer MZ, Frey JM, Griffiths RR. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure. Behavioural Pharmacology. 9: 545-59. PMID 9862080 DOI: 10.1097/00008877-199811000-00010  0.624
1998 Frey JM, Mintzer MZ, Rush CR, Griffiths RR. Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure. Psychopharmacology. 138: 16-26. PMID 9694522 DOI: 10.1007/S002130050640  0.648
1997 Mintzer MZ, Frey JM, Yingling JE, Griffiths RR. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behavioural Pharmacology. 8: 561-74. PMID 9832970 DOI: 10.1097/00008877-199711000-00014  0.715
1997 Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers. Experimental and Clinical Psychopharmacology. 5: 203-15. PMID 9260068 DOI: 10.1037/1064-1297.5.3.203  0.644
1993 Snodgrass JG, Mintzer M. Neighborhood effects in visual word recognition: facilitatory or inhibitory? Memory & Cognition. 21: 247-66. PMID 8469133 DOI: 10.3758/BF03202737  0.568
Show low-probability matches.